H.R. 2883: Stop Stalling Access to Affordable Medications

CBO Score


Date of Report

Fri July 22nd, 2022

CBO Report Details

Legislation Details

117th Congress

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.

Sponsor: Rep. Hakeem Jeffries — D — NY

Makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $5...

View the full vote history of this bill on GovTrack.us.

As a registered user, you receive personalized updates to your inbox or dashboard when elected officials vote to spend more of your money. Choose to receive updates daily, weekly, monthly, or as they happen.


Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.

Lost your Password?

Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.

+ + HIGH LOW +
+ + HIGH LOW +